Please login to the form below
Tofersen
This page shows the latest Tofersen news and features for those working in and with pharma, biotech and healthcare.
Biogen’s R&D chief Ehlers heads for the exit
There’s still plenty in the neuroscience pipeline however, including tofersen for amyotrophic lateral sclerosis (ALS) which stems from an alliance with antisense specialist Ionis and is due for a phase
Latest news
-
Biogen’s tofersen shows promise in slowing down ALS
Hope for subset of patients with wasting disease. Biogen has revealed promising preliminary data for tofersen, a potential treatment for the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS). ... Tofersen is just one of seven candidates
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Novavax gets $1.6bn from US government for coronavirus vaccine
- Communiqué Awards 2020: Results - Communiqué Awards
- FDA approves Roche’s Actemra COVID-19 trial
- Communiqué Awards 2020: Results - Communiqué Awards
- Mesoblast expands compassionate use COVID-19 programme
- Regeneron’s COVID-19 antibody cocktail enters phase 3 trial
- Intelligence that redefines success
- IFPMA launches AMR Action Fund to tackle antimicrobial resistance
- Merck expands partnership with Zymeworks for multispecific antibodies
- Novartis reveals full phase 3 results for Enerzair Breezhaler
- Artificial Intelligence in Digital Therapeutics
- CHECKLIST 04: Let’s make your patient recruitment strategies a success
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- CHECKLIST 04: Let’s make your patient recruitment strategies a success
- From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
- Multichannel engagement and the need for greater understanding of European markets
- By Laurence Olding and Georgina James...
- A snapshot of… Exscientia
- ...
Quick links
Infographics
